<DOC>
	<DOCNO>NCT00712218</DOCNO>
	<brief_summary>To assess efficacy systematic pelvic para-aortic lymphadenectomy patient advanced ovarian cancer intra-abdominal complete debulking . Secondary : progression-free survival , complication quality life ; Exploratory : Role number resect lymph node primary secondary objective</brief_summary>
	<brief_title>Lymphadenectomy In Ovarian Neoplasms</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>Primary diagnosis invasive epithelial ovarian cancer FIGO stage IIBIV ( IV resectable metastasis pleura , liver , spleen , and/or abdominal wall ) Macroscopic complete resection Age : 18 75 year Patients give sign write informed consent Good performance status ( ECOG 0/1 ) Non epithelial ovarian malignancy borderline tumor Intraoperative clinically suspicious lymph node ( bulky node ) Secondary invasive neoplasm last 5 year ( except synchronal endometrial carcinoma FIGO IA G1/2 , non melanoma skin cancer , breast cancer T1 N0 M0 G1/2 ) sign relapse activity . Recurrent ovarian cancer Prior chemotherapy ovarian cancer abdominal/pelvic radiotherapy Diseases lymph system ( include lymph edema unknown origin ) Clinical relevant dysfunction blood clotting ( include medicamentous condition reason , e.g . ASS , stop least 7 day prior surgery ) Any significant medical reason , age performance status allow perform study procedure ( estimation investigator ) Prior retroperitoneal lymph node dissection ( systematic sampling ) Pregnancy Dementia significantly alter mental status would prohibit understanding give informed consent Any reason interfere regular followup</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Ovarian cancer , FIGO stage IIB-IV</keyword>
</DOC>